| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(94)80111-8 |
| P698 | PubMed publication ID | 7814810 |
| P2093 | author name string | Leuschner U | |
| Imhof M | |||
| Leuschner M | |||
| Güldütuna S | |||
| Hübner K | |||
| Benjaminov A | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Serum bilirubin: a prognostic factor in primary biliary cirrhosis | Q34494336 | ||
| Daily fluctuation of cholestatic enzymes in bile and its relationship to the total bile salts concentration | Q39299963 | ||
| Enzyme profiles of mammalian bile | Q39936046 | ||
| Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study | Q41916901 | ||
| Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis | Q42192520 | ||
| Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. | Q42199158 | ||
| The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. | Q43973385 | ||
| The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis | Q45024371 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III. | Q54096014 | ||
| Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis. | Q54103179 | ||
| On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other | Q55953061 | ||
| Glutamate dehydrogenase: a reliable marker of liver cell necrosis in the alcoholic | Q57388042 | ||
| Evaluation of colchicine therapy in primary biliary cirrhosis | Q68139571 | ||
| A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis | Q68505504 | ||
| Factors of prognostic importance in primary biliary cirrhosis | Q68712203 | ||
| Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study | Q68781360 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival | Q69738156 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease | Q69971289 | ||
| Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients | Q70109771 | ||
| A prospective trial of D-penicillamine in primary biliary cirrhosis | Q70210395 | ||
| Bile acid-dependent secretion of alkaline phosphatase in rat bile | Q70401470 | ||
| High performance liquid chromatographic determination of free and conjugated bile acids in serum, liver biopsies, bile, gastric juice and feces by fluorescence labeling | Q70658117 | ||
| P433 | issue | 4 | |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 624-633 | |
| P577 | publication date | 1994-10-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis | |
| P478 | volume | 21 |
| Q42545724 | A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease |
| Q35358467 | Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment |
| Q34687676 | Drug therapy of primary biliary diseases: classical and modern strategies. |
| Q42254171 | Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages |
| Q74571363 | Immunosuppressive effects of ursodeoxycholic acid in heart-allografted rats |
| Q42555269 | Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy |
| Q73715566 | Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver |
| Q74529900 | Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis |
| Q43226120 | Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. |
| Q73026352 | Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial |
| Q56428272 | Primary biliary cirrhosis |
| Q58376775 | Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis |
| Q77807948 | Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group |
| Q74666028 | The effect of bile salts and calcium on isolated rat liver mitochondria |
| Q99584665 | Tubulointerstitial Nephritis Cases With IgM-Positive Plasma Cells |
| Q71605603 | Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis |
| Q39677430 | Ursodeoxycholic acid and superoxide anion |
| Q42551010 | Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study |
Search more.